New DEX Ruler In Town: dYdX Takes Over Uniswap With $757M Daily Volume


The decentralized exchange (DEX) market has been experiencing significant growth and competition in recent years. One platform that has emerged as a dominant player in this space is dYdX.

According to a recent report by CoinDesk, dYdX has surpassed Uniswap to become the largest DEX by daily trading volume. Data from CoinMarketCap shows that dYdX recorded a trading volume of $757 million, outperforming Uniswap v3, which had a volume of $608 million.

dYdX’s success can be attributed to its v3 and v4 versions. In 2023, dYdX’s v3 recorded over $1 trillion in trading volume, with some days exceeding $2 billion. Since going live, the total trade volume for its v4 market is $17.8 billion.

One significant move made by dYdX was its migration from Ethereum to Cosmos. Despite initial apprehensions about this shift, the robust trading volumes on dYdX demonstrate the success of the company’s choice. This move allowed dYdX to leverage the benefits of the Cosmos ecosystem, such as scalability and interoperability.

dYdX is well-known for its perpetual futures trading, which enables investors to speculate on the price of various assets. The platform made a transition to v4, a fully decentralized chain, from its previous v3 chain. Although a specific closure date for v3 on Ethereum has not been announced yet, the company intends to shut it down.

The success and growth of dYdX can also be attributed to the strong backing it has received from leading companies in the crypto industry. Pantera, Paradigm, and Delphi Digital are among the investors supporting dYdX, which further validates its potential and market position.

As the decentralized finance (DeFi) space continues to evolve and attract more users and investors, platforms like dYdX are playing a crucial role in providing decentralized and efficient trading solutions. With its impressive trading volumes and innovative features, dYdX is likely to maintain its position as a dominant DEX in the market.

Disclaimer: This article was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.

Leave a Reply

Your email address will not be published. Required fields are marked *